By: Jason Mast, Matthew Herper
By Matthew Herper and Jason Mast March 13, 2024 A series of new studies are raising hopes that CAR-T , a process in which treatments are
Senior Writer, Medicine, and Editorial Director, Events
Matthew Herper is a Senior Writer for STAT and the Editorial Director of Events. With a focus on medicine and biology, he covers a wide range of topics including the latest developments in healthcare, scientific breakthroughs, and the pharmaceutical industry. Matthew's work provides in-depth analysis and reporting on complex medical issues, making it accessible to a broad audience.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Matthew Herper's coverage primarily focuses on the healthcare and pharmaceutical sectors, with an emphasis on data-driven insights and industry announcements. His articles frequently cite data, incorporate press releases, and feature private sector announcements.
Given his extensive use of data in reporting, he may be particularly interested in sources who can provide statistical analysis or empirical evidence related to developments in pharmaceuticals, medical research, cancer treatment, gene editing, or drug development.
He does not appear to have a specific geographic focus but provides comprehensive coverage of global trends within the healthcare and pharmaceutical industries. When reaching out to him with pitches or expert commentary offers it should align with these thematic areas for higher chances of engagement.
This information evolves through artificial intelligence and human feedback. Improve this profile .